Product Watermark Icon
VirD Icon

VirD™ Functional Membrane Protein Virion Display Microarray

Functional GPCRs Embedded in a Cell Membrane

VirD™ microarrays use a patented system to synthesize important drug targets with  proper folding and function.

REQUEST INFO

Correctly-folded Functional Membrane Proteins

G protein-coupled receptors (GPCRs) and other membrane proteins play critical roles in a wide variety of physiological processes, and mutations in GPCRs are implicated in many diseases. GPCR receptors must be embedded in a cell membrane to fold correctly and are difficult to express in traditional recombinant expression systems. The most common method used to study GPCRs is to overexpress them in transfected mammalian cell lines. However, the transfected cells also contain endogenous receptors, making it a challenge to interpret experimental results.

CDI Labs now offers a viral-based expression technology to express individual GPCRs and other proteins embedded in a cell membrane. Purified virions displaying correctly-folded proteins are printed onto glass to create VirD arrays. This method eliminates the problem of endogenous cell receptors found when using traditional methods, and yields much cleaner data.

VirD Overview Figure

VirD Membrane Protein Array Validation and Production

VirD is a microarray that uses virions to display functional membrane proteins like GPCRs and is useful for drug development and functional assays.

VirD Membrane Protein Array Validation and Production Figure

VirD Technology Overview

VirD, a viral-based expression technology, expresses individual GPCR proteins embedded in a cell membrane. Purified virions displaying correctly-folded GPCRs are printed onto glass to create VirD arrays. This method eliminates the problem of endogenous receptor competition when using traditional methods, and yields much cleaner data.

Customer Testimonial

"We enjoyed working with CDI Labs. We used both VirScan and HuScan services from CDI Labs as part of our neurodegenerative disease research. The team at CDI Labs was very responsive and great to work with, and they went above and beyond to get us our results very quickly. They were particularly helpful in making contract arrangements and ensuring that everything was in place for a smooth collaboration. CDI Labs also provided a comprehensive statistical analysis, which will be invaluable as we build on our research. We’re still analyzing the data, but we’re confident that we’ll gain new insights into disease mechanisms that will advance our research."

Wouter Peelaerts, PhDProfessor, KU Leuven

Customer Testimonial

"CDI Labs provide consistent service and consistently high-quality protein array products to our lab. Their sales and scientific team are courteous and timely in their responses to our queries.”

Dr. Andrew McKeonMayo Clinic College of Medicine & Science

Data and technology validated by scientists

"We elected to use the HuProt Microarray because it is an extensive platform that contains over 21,000 unique, individually purified full-length human proteins and protein isoforms in duplicate, covering more than 81% of the proteome."

OncologistSchool of Medicine Research (as mentioned in "Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade" - AACR Clinical Caner Research - September 2022)

Data and technology validated by scientists

"This (VirScan) assay, which uses phage display immunoprecipitation and sequencing, is a sensitive and focused high-comprehensive approach that enables thorough serological profiling of antiviral antibodies in humans and, consequently, the identification of viral exposure throughout the human virome."

Faculty of MedicineResearch Institution (as mentioned in "Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8+ T cells in patients with advanced NSCLC" - Science Advances - November 2023)

Data and technology validated by scientists

"By using (HuProt) protein arrays, we were able to evaluate a broader range of antigens compared to previous investigations."

Senior ScientistBiotech Research (poster presentation at the San Antonio Breast Cancer Symposium 2023)